Glaxo Says Its Covid-19 Antibody Drug Works Against Omicron

Redirecting to full article in 5 second(s)...

GlaxoSmithKline and Vir said their Covid-19 antibody treatment retained effectiveness against the Omicron variant in laboratory studies, even as early data suggests that similar treatments work less well against the strain.